mhra
MHRA publishes Patient and Public Involvement and Engagement Plan 2026–2030
The MHRA’s plan aims to strengthen patient, carer and public involvement in regulatory decisions, including medical devices. Its activity timeframe needs clarification.
What Changed
The Medicines and Healthcare products Regulatory Agency (MHRA) has published its Patient and Public Involvement and Engagement Plan 2026–2030. The corporate plan sets out an approach to placing meaningful involvement and engagement at the centre of the agency’s work.
It builds on progress under the Patient Involvement Strategy 2021–2025. Priorities include strengthening partnerships, improving opportunities for involvement and demonstrating how patient and public contributions influence regulatory decisions and outcomes.
Who Is Affected
The plan addresses patients, carers and the wider public. Its scope includes participation in regulatory decisions concerning medicines safety, medical devices and emerging technologies.
For medical-device manufacturers and other stakeholders, it provides context on how the MHRA intends to bring a broader range of voices and experiences into its work.
Regulatory and Technical Implications
The MHRA identifies inclusive engagement, transparency and collaboration as guiding principles. The emphasis is on participation in the agency’s work and the influence of that participation on decisions.
The publication page does not specify new device technical requirements, conformity assessment changes or manufacturer submission obligations.
Manufacturer Actions
Manufacturers can consult the plan to understand the MHRA’s engagement priorities and its intention to demonstrate the contribution of patient and public perspectives.
The publication page identifies no specific manufacturer action or associated compliance deadline.
Confirmed Dates
The publication date is 5 November 2026. The plan’s title and stated overall scope cover 2026–2030.
However, the MHRA also describes priorities and planned activities over “the next three years”. The relationship between that wording and the 2026–2030 period is not explained, leaving the detailed implementation timeframe unclear.
Official Source
The MHRA’s GOV.UK publication page lists an HTML edition, a 24-page PDF and a 22-page easy-read edition.
Https://www.gov.uk/government/publications/patient-and-public-involvement-and-engagement-plan-2026-2030
Source and related services
Corporate report: Patient and Public Involvement and Engagement Plan 2026-2030 ↗Source date: 05/11/2026
This news provides general information and does not replace device-specific legal or conformity assessment advice.